May 13, 2021
Pharmaceutical manufacturer Indivior said that a former employee's False Claims Act retaliation claims should be axed, calling her case "the latest in a long line of attempts … to cash in on her departure."
April 27, 2021
Pharmaceutical manufacturer Indivior has finalized an agreement to pay a total of $300 million to all 50 states to settle allegations it falsely and aggressively marketed the opioid-based drug Suboxone, an alleged scheme that led to the misuse of Medicaid funds, according to a settlement released by the California Attorney General's office Tuesday.
July 12, 2019
An addiction specialist looking to take on Reckitt Benckiser's marketing practices for its opioid treatment found a path to victory by filing a whistleblower suit so that the federal government would get involved, culminating in a record-breaking $1.4 billion deal.